BridgeBio Pharma Inc.
BBIO | NASDAQ
$75.86
+$0.91 (+1.21%)
Nov 2, 2026, 11:44 AM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 353.17M | 243.68M | 194.52M | 154.18M | 120.7M | 110.57M | 116.63M | 5.88M | 2.73M | 2.17M | 211.12M | 1.75M | 4.09M | 1.64M | 1.83M | 1.87M | 338K | 73.75M | 1.69M | 12.89M | 2.34M | 54.02M | 462K |
Cost of Revenue | 20.45M | 15.05M | 10.43M | 15.42M | 6.56M | 3.65M | 2.64M | 2.08M | 598K | 598K | 598K | 598K | 598K | 599K | 651K | 647K | 739K | 700K | 1.35M | 1.55M | 1.45M | 109K | n/a |
Gross Profit | 332.72M | 228.63M | 184.09M | 138.76M | 114.14M | 106.91M | 113.99M | 3.8M | 2.13M | 1.57M | 210.52M | 1.15M | 3.49M | 1.04M | 1.18M | 1.22M | -401K | 73.05M | 346K | 11.34M | 890K | 53.92M | 462K |
Operating Income | -11.64M | -107.08M | -105.96M | -185.24M | -145.2M | -134.28M | -104.37M | -226.03M | -191.75M | -175.54M | 343K | -177.42M | -157.69M | -146.1M | -126.16M | -129.23M | -129.12M | -80.18M | -173.68M | -165.61M | -149.5M | -94.02M | -167.5M |
Interest Income | 13.11M | 6.66M | 6.25M | 4.33M | 6.24M | 3.9M | 5.39M | 4.68M | 3.3M | 5.2M | 4.08M | 5.58M | 3.79M | 4.51M | 4.15M | 4.09M | 2.42M | 766K | 267K | 182K | 234K | 323K | 394K |
Pretax Income | -59.27M | -155.89M | -166.56M | -197.24M | -186.48M | -181.66M | -169.61M | -266.24M | -164.25M | -75.54M | -36.16M | -170.33M | -179.49M | -160.7M | -142.73M | -140.57M | -140.19M | -2.56M | -201.33M | -152.28M | -161.02M | -102.07M | -171.08M |
Net Income | -56.71M | -152.22M | -164.04M | -197.24M | -182.74M | -181.9M | -167.42M | -265.05M | -162.04M | -73.46M | -35.22M | -168.15M | -177M | -157.9M | -140.16M | -137.59M | -137.34M | -9.86M | -196.4M | -147.18M | -155.94M | -96.35M | -163.08M |
Selling & General & Admin | 200.85M | 186.26M | 163.9M | 182M | 137.62M | 129.15M | 106.37M | 94.78M | 68.82M | 59.52M | 65.81M | 47.58M | 35.78M | 36.12M | 31.11M | 31.86M | 31.19M | 36.43M | 43.71M | 54.75M | 46.08M | 45.97M | 45.41M |
Research & Development | 143.51M | 149.45M | 126.64M | 142M | 112.87M | 111.23M | 111.43M | 130.35M | 120.44M | 114.7M | 140.97M | 130.23M | 125.14M | 107.49M | 92.86M | 90.9M | 92.51M | 108.4M | 107.65M | 122.2M | 104.31M | 101.96M | 122.56M |
Other Expenses | n/a | n/a | -486K | n/a | 8.84M | 805K | 570K | 4.69M | 4.62M | 2.89M | 3.4M | 754K | 272K | 3.53M | 3.37M | 7.69M | 5.02M | 8.4M | 22.66M | n/a | n/a | n/a | n/a |
Operating Expenses | 344.36M | 335.71M | 290.05M | 324M | 259.34M | 241.19M | 218.37M | 229.83M | 193.88M | 177.11M | 210.18M | 178.56M | 161.19M | 147.14M | 127.34M | 130.46M | 128.72M | 153.22M | 174.02M | 176.95M | 150.39M | 147.93M | 167.97M |
Interest Expense | 55.54M | 13.28M | 52.82M | 12M | 11.74M | 37.64M | 42.14M | 29.82M | 23.06M | 22.94M | 23.47M | 20.27M | 20.31M | 20.59M | 20.12M | 19.99M | 19.83M | 20.28M | 20.34M | 15.13M | 11.07M | 10.84M | 9.74M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 364.81M | 350.76M | 300.47M | 339.42M | 265.9M | 244.84M | 221.01M | 231.91M | 194.48M | 177.71M | 210.78M | 179.16M | 161.78M | 147.74M | 127.99M | 131.1M | 129.45M | 153.92M | 175.37M | 178.5M | 151.84M | 148.04M | 167.97M |
Income Tax Expense | 1.23M | n/a | n/a | n/a | -1.55M | 2.1M | n/a | 1.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 196.03M | 195.79M | 194.79M | 197.24M | 190.52M | 190.52M | 190.15M | 189.44M | 188.51M | 187.59M | 178.71M | 174.46M | 163.31M | 160.54M | 152.65M | 149.34M | 147.94M | 146.68M | 145.88M | 145.28M | 146.66M | 146.75M | 138.63M |
Shares Outstanding (Diluted) | 196.03M | 195.79M | 194.79M | 197.24M | 190.52M | 190.52M | 190.15M | 189.44M | 188.51M | 187.59M | 178.71M | 174.46M | 163.31M | 160.54M | 152.65M | 149.34M | 147.94M | 146.68M | 145.88M | 145.28M | 146.66M | 146.75M | 138.63M |
EPS (Basic) | -0.42 | -0.78 | -0.84 | -1 | -0.96 | -0.95 | -0.88 | -1.40 | -0.86 | -0.39 | -0.20 | -0.96 | -1.08 | -0.98 | -0.92 | -1.04 | -1 | -0.07 | -1.35 | -1.01 | -1.06 | -0.66 | -1.18 |
EPS (Diluted) | -0.42 | -0.78 | -0.84 | -1 | -0.96 | -0.95 | -0.88 | -1.40 | -0.86 | -0.39 | -0.20 | -0.96 | -1.08 | -0.98 | -0.92 | -1.04 | -1 | -0.07 | -1.35 | -1.01 | -1.06 | -0.66 | -1.18 |
EBITDA | -2.66M | -141.56M | -112.55M | -183.8M | -173.35M | -142.7M | -126.18M | -235.05M | -139.66M | -51.03M | -11.09M | -148.48M | -157.54M | -138.47M | -120.98M | -118.92M | -118.72M | 19.3M | -179.1M | -135.62M | -149.68M | -87.75M | -160.78M |
EBIT | -3.73M | -142.61M | -113.74M | -185.24M | -174.74M | -144.02M | -127.47M | -236.42M | -141.19M | -52.61M | -12.69M | -150.06M | -159.18M | -140.11M | -122.61M | -120.58M | -120.37M | 17.72M | -180.99M | -137.15M | -149.95M | -91.24M | -161.34M |
Depreciation & Amortization | 1.07M | 1.05M | 1.19M | 1.44M | 1.4M | 1.32M | 1.28M | 1.37M | 1.54M | 1.57M | 1.6M | 1.59M | 1.64M | 1.64M | 1.63M | 1.66M | 1.65M | 1.58M | 1.88M | 1.53M | 265K | 3.49M | 566K |
Add to Watchlist
Select watchlists to add or remove BBIO